(Q39287947)

10 September 2017

Primary culture and immortalization of human fallopian tube secretory epithelial cells (English)

1 reference

10 September 2017

0 references

1 reference

2

1 reference

10 September 2017

Alison M Karst

1

1 reference

10 September 2017

30 August 2012

1 reference

10 September 2017

1 reference

10 September 2017

7

1 reference

10 September 2017

9

1 reference

10 September 2017

1755-1764

1 reference

PubMed ID

22936217

describes a project that uses

10 September 2017

FT33-shp53-R24C

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/nprot.2012.097

0 references

cites work

Modeling high-grade serous ovarian carcinogenesis from the fallopian tube

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Intercepting pelvic cancer in the distal fallopian tube: theories and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

The fallopian tube: primary site of most pelvic high-grade serous carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Ovarian cancer pathogenesis: a model in evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

New insights into the pathogenesis of serous ovarian cancer and its clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Precursors to pelvic serous carcinoma and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

The new face of ovarian cancer modeling: better prospects for detection and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Role of genetic polymorphisms and ovarian cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Common variants at 19p13 are associated with susceptibility to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

A simple and quick method to concentrate MSCV retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Are all pelvic (nonuterine) serous carcinomas of tubal origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Ex vivo culture of primary human fallopian tube epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2012.097

PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22936217

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NPROT.2012.097

1 reference

10 September 2017

0 references

1 reference

PubMed ID

22936217